Title: Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/
CD166+ by inhibiting programmed death-ligand 1
Version: 5 Date: 29 Oct 2024
Reviewer's report:
Concentration of rhaponticin used should be defined in the abstract and the text In the methods
section isolation using microbeads  should be also included there
Title: Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/
CD166+ by inhibiting programmed death-ligand 1
Version: 5 Date: 29 Oct 2024
Reviewer's report:
Concentration of rhaponticin used should be defined in the abstract and the text In the methods
section isolation using microbeads  should be also included there
Please review this paper.
user
Title: Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/
CD166+ by inhibiting programmed death-ligand 1
Version: 5 Date: 29 Oct 2024
Reviewer's report:
Concentration of rhaponticin used should be defined in the abstract and the text In the methods
section isolation using microbeads  should be also included there
assistant